Clarithromycin
23 NDCs across 10 manufacturers|23 Generic,0 Brand
Clarithromycin is used to treat bronchitis, chlamydia infections, duodenal ulcer, haemophilus infections, helicobacter infections and nontuberculous mycobacterium infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 31, 1991, and the first generic was approved May 25, 2004. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $5 million on Clarithromycin across 196,000 claims for 166,000 beneficiaries.
Clarithromycin is available as 23 NDCs from 10 manufacturers (23 generic, 0 brand), with NADAC prices from $0.37 to $1.92 per EA — the most expensive product costs about 5.2× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
23
23G / 0B
Manufacturers
10
competing in market
Price Spread
$0.37 – $1.92
per EA, 19 of 23 NDCs
7d Activity
avg +3.5% WoW · of 23 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sandoz Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Macrolide Antimicrobial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing CLARITHROMYCIN(1 pricing outlier)
Frequently Asked Questions
What is Clarithromycin used to treat?
Clarithromycin is used to treat bronchitis, chlamydia infections, duodenal ulcer, haemophilus infections, helicobacter infections and nontuberculous mycobacterium infections, per the National Library of Medicine's MED-RT classification.
When did Clarithromycin become available as a generic?
FDA approved the first generic Clarithromycin (ANDA) on May 25, 2004. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Clarithromycin?
In 2024, Medicare Part D spent $5 million on Clarithromycin across 196,000 claims for 166,000 beneficiaries.
How many Clarithromycin products are on the market?
The Clarithromycin drug market contains 23 NDCs from 10 manufacturers — 23 generic and 0 brand products.
What is the price range for Clarithromycin?
NADAC reference prices for Clarithromycin range from $0.3707 to $1.9182 per EA — the most expensive product costs about 5.2× the cheapest. 4 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Clarithromycin?
10 manufacturers list Clarithromycin in NADAC. Ranked by number of NDCs, the largest are Sandoz Inc. (6), Lannett Company Inc. (3), Chartwell RX LLC (3), Rising Pharma Holdings Inc. (2), Aurobindo Pharma Limited (2).
How has the price of Clarithromycin changed recently?
Over the past 7 days, 18 Clarithromycin NDCs rose and 2 fell, with a market-wide average change of +3.5%.